BRD2 and glioblastoma: Six of these transcripts were overexpressed in recurrence, including the bromodomain gene BRD2 (padj = 9.3 × 10−3), thought to be essential to glioblastoma cell cycle maintenance [20] and an emerging therapeutic target [21,22].